A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- SC 13G/A74.6 KBALDER BIOPHARMACEUTICALS INCFeb 13, 4:18 PM ET·0001387131-20-001549
- SC 13G122.7 KBALDER BIOPHARMACEUTICALS INCOct 31, 4:27 PM ET·0000902664-19-004139
- SC 13D/A74.4 KBALDER BIOPHARMACEUTICALS INCOct 24, 6:55 PM ET·0001193125-19-273714
- SC 13D/A66.3 KBALDER BIOPHARMACEUTICALS INCOct 24, 4:28 PM ET·0001104659-19-056127
- 8-K506.2 KBALDER BIOPHARMACEUTICALS INCOct 22, 9:03 AM ET·0001193125-19-271319
- SC 13G/A7.0 KBALDER BIOPHARMACEUTICALS INCOct 10, 12:47 PM ET·0000080255-19-002968
- SC 13G/A32.9 KBALDER BIOPHARMACEUTICALS INCOct 10, 12:11 PM ET·0000902219-19-000458
- SC 13D113.9 KBALDER BIOPHARMACEUTICALS INCSep 26, 1:26 PM ET·0001193125-19-255708
- SC 13D/A84.1 KBALDER BIOPHARMACEUTICALS INCSep 17, 4:20 PM ET·0001144204-19-044908
- 8-K1.2 MBALDER BIOPHARMACEUTICALS INCSep 16, 9:25 AM ET·0001193125-19-245486
Insiders
10- Azelby RobertDirector, President and CEO
- BAYLESS JON WAffiliate
- Benedict LarrySr. VP Finance
- Bridger GaryDirector
- Bucher James BSr. VP & General Counsel
- Campoy CarlosChief Financial Officer
- Carter Eric GInterim Chief Medical Officer
- Carter Paul RutherfordDirector
- Cleveland Paul BDirector
- Dac NadiaChief Commercial Officer
Tickers
No tickers on record
Addresses
business
11804 NORTH CREEK PARKWAY SOUTH
BOTHELL, WA, 98011
mailing
11804 NORTH CREEK PARKWAY SOUTH
BOTHELL, WA, 98011